ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE backs use of Roche's Gazyvaro with bendustamine
May 14, 2020Patients with follicular lymphoma will now get NHS-funded treatment with Roche's Gazyvaro (binutuzumab)/bendamustine in England and Wales after cost regulators published guidelines backing its use in this setting. -
Venclyxto gains approval in Europe
March 16, 2020The European Commission has approved Venclyxto (venetoclax) in combination with Gazyvaro (obinutuzumab) for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL). -
Four new medicines available via NHS Scotland
November 27, 2018The Scottish Medicines Consortium has cleared funds for use of four new medicines by NHS Scotland, including Sanofi’s biologic Dupixent for dermatitis. -
Roche hails 4 year NICE access deal for Gazyvaro
July 27, 2017NICE has agreed a deal with Roche on its new follicular lymphoma treatment Gazyvaro, giving the drug up to four years to prove its value to patients.
Pharma Sources Insight January 2025
